China Healthwise Holdings stock analysis
Want to see HK:0348 full AI Analyst Report?
China Healthwise Holdings (0348) Stock Price & Analysis
0348 Stock Chart & Stats
- Day’s Range
- HKD 0.07 - HKD 0.07
- 52-Week Range
- HKD 0.05 - HKD 0.21
- Previous Close
- HKD 0.07
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- HKD 67.49M
- Enterprise Value
- HKD 115.06M
- Total Cash (Recent Filing)
- HKD 22.69M
- Total Debt (Recent Filing)
- HKD 94.61M
- Price to Earnings (P/E)
- ―
- Beta
- -0.11
- Next Earnings
- Mar 29, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Positive Cash Generation
Positive operating and free cash flow in 2024–2025 indicates some ability to convert operations into cash despite reported losses. This provides internal funding for essential needs, although the roughly HK$3m annual scale remains modest relative to debt.
Improving Gross Margin
Improved gross margin and sharply reduced 2025 net loss show that operating economics moved in a better direction. If sustained, this can narrow the path to breakeven and make existing revenue more valuable, though negative operating margins mean the benefit is not yet durable.
Stable Asset Base
A relatively stable asset base provides continuity for the company’s operations and avoids evidence of broad asset shrinkage in the reported period. This may support ongoing business activity, although stability alone does not resolve the company’s leverage or equity deficit.
Bears Say
Declining Revenue
Recent revenue declines indicate weakening business scale and reduce the company’s ability to spread fixed costs across a larger sales base. Without a return to sustained growth, the improved gross margin may not translate into stronger earnings or durable cash generation.
Negative Shareholder Equity
Negative shareholder equity signals a highly stressed capital structure and materially limits financial flexibility. Debt representing most of the reported asset base increases the importance of continued cash generation, while the equity deficit makes absorbing further losses more difficult.
Persistent Operating Losses
Persistent losses and negative operating margins show that the core business has not yet reached sustainable profitability. This weakens internally generated capital, limits reinvestment capacity, and leaves the company dependent on improvement in revenue or margins to strengthen its financial position.
China Healthwise Holdings News
China Healthwise Wins Shareholder Backing for Share Consolidation Effective 22 September 2026
An update from China Healthwise Holdings ( ($HK:0348) ) is now available. Shareholders of China Healthwise Holdings Limited have approved a share consolidation at an extraordinary general meeting held on
China Healthwise Completes HK$10.8 Million Share Subscription to Fund Operations and Debt Interest
China Healthwise Holdings ( ($HK:0348) ) has provided an announcement. China Healthwise Holdings Limited has completed a subscription of 154.09 million new shares under its general mandate, representing about 16.7%
0348 FAQ
What was China Healthwise Holdings’s price range in the past 12 months?
What is China Healthwise Holdings’s market cap?
When is China Healthwise Holdings’s upcoming earnings report date?
How were China Healthwise Holdings’s earnings last quarter?
Is China Healthwise Holdings overvalued?
Does China Healthwise Holdings pay dividends?
What is China Healthwise Holdings’s EPS estimate?
How many shares outstanding does China Healthwise Holdings have?
What happened to China Healthwise Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of China Healthwise Holdings?
What is the TipRanks Smart Score and how is it calculated?
China Healthwise Holdings Stock Smart Score
Company Description
China Healthwise Holdings
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand. It is also involved in money lending business; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong.
- Sector
- Healthcare
- Industry
- Leisure
- CEO
- Hong Wai Lei
- Employees
- 76
- Website
- www.healthwisehk.com
- Address
- HK
China Healthwise Holdings (0348) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 4 | 10 |
| Technical Analysis | 2 | 4 | 2 |
| Moving Averages | 4 | 0 | 8 |








